A5012004822- COVID-19 Clinical Research Studies
- Pharmaceutical Practices and Patient Outcomes
- Vitamin C and Antioxidants Research
- Patient Safety and Medication Errors
- COVID-19 and Mental Health
- COVID-19 and healthcare impacts
- Neuroendocrine Tumor Research Advances
- Optimism, Hope, and Well-being
- Coronary Artery Anomalies
- Cardiovascular Disease and Adiposity
- Mechanical Circulatory Support Devices
- Diabetes Treatment and Management
- Healthcare Operations and Scheduling Optimization
- Cardiovascular Health and Risk Factors
- Medical Malpractice and Liability Issues
- Operations Management Techniques
- Kawasaki Disease and Coronary Complications
Glasgow Royal Infirmary
2023
NHS Greater Glasgow and Clyde
2021-2023
University of Glasgow
2021
Cleveland Clinic
2010
<b>PURPOSE</b> In this study, we developed and field tested the Medication Error Adverse Drug Event Reporting System (MEADERS)—an easy-to-use, Web-based reporting system designed for busy office practices. <b>METHODS</b> We conducted a 10-week test of MEADERS in which 220 physicians staff from 24 practices reported medication errors adverse drug events they observed during usual clinical care. The main outcomes were (1) use acceptability measured with postreporting survey interviews managers...
Post-COVID-19 syndromes have associated with female sex, but the pathophysiological basis is uncertain.There are sex differences in myocardial inflammation identified using cardiac magnetic resonance (CMR) post-COVID-19 patients, and patient reported health outcomes following COVID-19 infection.This prospective study investigated time-course of multiorgan injury survivors during convalescence.Clinical information, blood biomarkers, outcome measures were prospectively acquired at enrolment...
BMA guidance recommends all hospitals provide suitable, comfortable and convenient period products. In 2018, none of Scotland's health boards had policies on sanitary product provision.Establish current provision at Glasgow Royal Infirmary.Improve for staff patients.Improve working experience while menstruating.Cycle 0: A pilot survey was circulated to assess provision, availability impact environment.Cycle 1: The hospital staff. Suppliers were contacted donations. Two menstrual hubs...
COVID-19 illness is associated with cardiovascular vulnerabilities at all stages pre-infection, acute phase and subsequent chronic phase. The major cardiometabolic drivers identified to have epidemiological mechanistic associations are abnormal adiposity, dysglycaemia, dyslipidaemia, hypertension. Recent findings demonstrate that risk reduction interventions may short-term benefits on outcomes. Our aim was investigate the effect of pharmacotherapy SARS-CoV-2 infection. Demographic data,...
Hypertension, vascular dysfunction and downregulation of the renin angiotensin system as sequelae COVID-19 The long-term CV consequences COVID are unknown however potential for ongoing cardiac inflammation with RAAS alteration may increase risk developing hypertension disease. Non-hypertensive patients hospitalised in April-May 2020 either confirmed COVID19 (cases) or non-COVID (controls) diagnosis were recruited ≥12 weeks post-discharge. All underwent detailed BP vascular/immune...